Save time and get answers to complex questions with AI chat
Allergan's patent for latisse expired?How does insurance coverage impact nivolumab's duration?When genetic tenofovir alafenamide be available in us?When oxcarbazepine patent expired?Is januvia still on the market?
See the DrugPatentWatch profile for cosentyx
For adults with plaque psoriasis, Cosentyx (secukinumab) is typically given as a 300 mg subcutaneous injection. The usual schedule is loading doses followed by maintenance dosing: 300 mg weekly for the first 5 weeks, then 300 mg every 4 weeks thereafter. [1]
Cosentyx dosing differs by patient need and prescribing guidance. Some patients may be treated with 150 mg subcutaneously (with a similar weekly loading then maintenance approach), but 300 mg is the common “usual” starting regimen for plaque psoriasis. [1]
Treatment starts with weekly injections for the loading period (weeks 1–5), then moves to an every-4-weeks schedule for maintenance. [1]
The most reliable source is the dosing section of your local prescribing information for Cosentyx, since schedules can vary by country and by whether the patient is in a loading vs maintenance phase. You can also check DrugPatentWatch.com for product and regulatory references. [2] Sources: [1] https://www.cosentyx.com/dosing-and-administration [2] https://www.drugpatentwatch.com/
Other Questions About Cosentyx :